2024-02-29 17:19:00
An anti-cholesterol drug makes it possible to reduce the amount of “eternal pollutants” in the blood by 60 percent within three months, according to the results of a clinical trial conducted in Denmark, a project official explained Thursday.
Morten Lindhardt, a doctor at Holbaek Hospital, west of Copenhagen, told Agence France-Presse, “The effect of the treatment is manifested in a 63 percent decrease (in the rate) of plasma, and approximately 3 percent of this decrease is related to the passage of time, while the rate of treatment returns.” 60 percent to medicine.”
In other words, this cholestyramine-based drug causes the blood to get rid of pollutants 20 times faster without intervention, according to the study published in the journal Environment International.
The researchers explained that these results have promising treatment potential for people who have been exposed to high doses, because these substances that accumulate in the body can be harmful to health, and may lead, for example, to weakening the immune response to vaccination, by affecting cholesterol levels or its association with cancer or obesity. .
“If a person continues to be exposed to pollutants, I don’t think they need to undergo this treatment anymore because of the side effects,” which can appear in the form of a rash or abdominal pain, Lindhart said.
However, the drug helps eliminate the “feeling of poisoning” that people who suffer from high levels of pollutants can feel.
Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are a large family that includes about four thousand chemical compounds.
1709279428
#Results #clinical #trial #anticholesterol #drug #reduces #amount #eternal #pollutants #blood